Literature DB >> 30578702

Genomic variability of within-host hepatitis C variants in acute infection.

Chaturaka Rodrigo1, Preston Leung2, Andrew R Lloyd2, Rowena A Bull1,2, Fabio Luciani1,2, Jason Grebely2, Gregory J Dore2, Tanya Applegate2, Kimberly Page3, Julie Bruneau4, Andrea L Cox5, William Osburn5, Arthur Y Kim6, Naglaa H Shoukry4, Georg M Lauer6, Lisa Maher2, Janke Schinkel7,8, Maria Prins7,8, Margaret Hellard9,10,11,12, Auda A Eltahla1.   

Abstract

Interactions between the host immune system and the viral variants determine persistence of hepatitis C virus (HCV) infection after the acute phase of infection. This study describes the genetic variability of within-host HCV viral variants in acute infection and correlates it with host- and virus-related traits and infection outcome. Next generation sequence data (Illumina, MiSeq platform) of viral genomes from 116 incident acute infections (within 180 days of infection) were analysed to determine all the single nucleotide polymorphism (SNP) frequencies above a threshold of 0.1%. The variability of the SNPs for the full open reading frame of the genome as well as for each protein coding region were compared using mean standardized Shannon entropy (SE) values calculated separately for synonymous and nonsynonymous mutations. The envelope glycoproteins regions (E1 and E2) had the highest SE values (indicating greater variability) followed by the NS5B region. Nonsynonymous mutations rather than synonymous mutations were the main contributors to genomic variability in acute infection. The mean difference of Shannon entropy was also compared between subjects after categorizing the samples according to host and virus-related traits. Host IFNL3 allele CC polymorphism at rs12979860 (vs others) and viral genotype 1a (vs 3a) were associated with higher genomic variability across the viral open reading frame. Time since infection, host gender or continent of origin was not associated with the viral genomic variability. Viral genomic variability did not predict spontaneous clearance.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  IFNL3; InC3 study; Shannon entropy; hepatitis C virus; spontaneous clearance

Mesh:

Substances:

Year:  2019        PMID: 30578702      PMCID: PMC6417964          DOI: 10.1111/jvh.13051

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  44 in total

1.  The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection.

Authors:  Jason Grebely; Kimberly Page; Rachel Sacks-Davis; Maarten Schim van der Loeff; Thomas M Rice; Julie Bruneau; Meghan D Morris; Behzad Hajarizadeh; Janaki Amin; Andrea L Cox; Arthur Y Kim; Barbara H McGovern; Janke Schinkel; Jacob George; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Maria Prins
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

2.  Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study.

Authors:  C Rodrigo; A A Eltahla; R A Bull; F Luciani; J Grebely; G J Dore; T Applegate; K Page; J Bruneau; M D Morris; A L Cox; W Osburn; A Y Kim; N H Shoukry; G M Lauer; L Maher; J Schinkel; M Prins; M Hellard; A R Lloyd
Journal:  J Viral Hepat       Date:  2016-11-03       Impact factor: 3.728

3.  Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimation.

Authors:  Vincent Montoya; Andrea D Olmstead; Naveed Z Janjua; Patrick Tang; Jason Grebely; Darrel Cook; P Richard Harrigan; Mel Krajden
Journal:  Hepatology       Date:  2015-03-18       Impact factor: 17.425

4.  IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.

Authors:  Ourania Koltsida; Michael Hausding; Athanasios Stavropoulos; Sonja Koch; George Tzelepis; Caroline Ubel; Sergei V Kotenko; Paschalis Sideras; Hans A Lehr; Marcus Tepe; Kevin M Klucher; Sean E Doyle; Markus F Neurath; Susetta Finotto; Evangelos Andreakos
Journal:  EMBO Mol Med       Date:  2011-05-03       Impact factor: 12.137

5.  Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.

Authors:  Donald B Smith; Jens Bukh; Carla Kuiken; A Scott Muerhoff; Charles M Rice; Jack T Stapleton; Peter Simmonds
Journal:  Hepatology       Date:  2014-01       Impact factor: 17.425

6.  Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification.

Authors:  Ashley Sobel Leonard; Micah T McClain; Gavin J D Smith; David E Wentworth; Rebecca A Halpin; Xudong Lin; Amy Ransier; Timothy B Stockwell; Suman R Das; Anthony S Gilbert; Robert Lambkin-Williams; Geoffrey S Ginsburg; Christopher W Woods; Katia Koelle
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

7.  Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment.

Authors:  Auda A Eltahla; Preston Leung; Mehdi R Pirozyan; Chaturaka Rodrigo; Jason Grebely; Tanya Applegate; Lisa Maher; Fabio Luciani; Andrew R Lloyd; Rowena A Bull
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

Review 8.  Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs.

Authors:  Ivan Zanoni; Francesca Granucci; Achille Broggi
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

9.  Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness.

Authors:  Luke Uebelhoer; Jin-Hwan Han; Benoit Callendret; Guaniri Mateu; Naglaa H Shoukry; Holly L Hanson; Charles M Rice; Christopher M Walker; Arash Grakoui
Journal:  PLoS Pathog       Date:  2008-09-05       Impact factor: 6.823

10.  The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.

Authors:  Annette von Delft; Isla S Humphreys; Anthony Brown; Katja Pfafferott; Michaela Lucas; Paul Klenerman; Georg M Lauer; Andrea L Cox; Silvana Gaudieri; Eleanor Barnes
Journal:  Gut       Date:  2015-06-19       Impact factor: 23.059

View more
  4 in total

1.  Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs.

Authors:  Vincent Montoya; Anita Y M Howe; Weiyan Y Dong; Winnie Dong; Chanson J Brumme; Andrea D Olmstead; Kanna Hayashi; P Richard Harrigan; Jeffrey B Joy
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

Review 2.  Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?

Authors:  Daniele Lapa; Anna Rosa Garbuglia; Maria Rosaria Capobianchi; Paola Del Porto
Journal:  Cells       Date:  2019-04-03       Impact factor: 6.600

3.  Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.

Authors:  Keylie M Gibson; Margaret C Steiner; Uzma Rentia; Matthew L Bendall; Marcos Pérez-Losada; Keith A Crandall
Journal:  Viruses       Date:  2020-07-14       Impact factor: 5.048

Review 4.  Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma.

Authors:  Kirk J Wangensteen; Kyong-Mi Chang
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.425

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.